Mus­tang ties the knot with Fred Hutch on next-gen CAR-T for lym­phoma

Back in ear­ly Feb­ru­ary, Mus­tang Bio — a sub of Fortress Biotech $FBIO — said it had raised a whop­ping $94.5 mil­lion to bol­ster its work …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.